Company news
Dri Healthcare Trust (TSX:DHT.U) news
Every Dri Healthcare Trust press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
DRI Healthcare Announces Receipt of Put Price on EKTERLY
August 11, 2026
DRI Healthcare Reports Second Quarter 2026 Results and New Board Appointment
August 7, 2026
DRI Healthcare to Host Second Quarter 2026 Earnings Call and Webcast on August 10, 2026
July 20, 2026
DRI Healthcare Announces Exercise of Put Option on EKTERLY®
July 10, 2026
DRI Healthcare Comments on Viridian's FDA Approval and Launch of Lumvoa(TM) (veligrotug-vvze)
June 29, 2026
DRI Healthcare Trust Announces Voting Results of Annual and Special Meeting
May 15, 2026
DRI Healthcare Reports First Quarter 2026 Results
May 14, 2026
DRI Healthcare Trust Comments on Proposed Acquisition of KalVista Therapeutics, Inc.
April 29, 2026
DRI Healthcare to Host First Quarter 2026 Earnings Call and Webcast on May 15, 2026
April 24, 2026
DRI Healthcare Trust (DHT.UN / DHT.U) Closes the Market
April 9, 2026
DRI Healthcare Trust Announces Closing of US$250 Million of Senior Secured Notes
March 25, 2026
DRI Healthcare Trust Announces Closing of Preferred Securities Refinancing
March 20, 2026
DRI Healthcare Reports Fourth Quarter and Annual 2025 Results
March 3, 2026
DRI Healthcare Trust Announces Preferred Securities Refinancing
March 2, 2026
DRI Healthcare to Host Fourth Quarter and Full Year 2025 Earnings Call and Webcast on March 4, 2026
February 11, 2026
DRI Healthcare Reports Third Quarter 2025 Results
November 5, 2025
DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment...
October 20, 2025
DRI Healthcare to Host Third Quarter 2025 Earnings Call and Webcast on November 6, 2025
October 16, 2025
DRI Healthcare Trust Promotes Zaheed Mawani to Chief Financial Officer
September 19, 2025
DRI Healthcare to Present at Upcoming Investor Conferences
September 16, 2025
DRI Healthcare Reports Second Quarter 2025 Results
August 13, 2025
DRI Healthcare to Host Second Quarter 2025 Earnings Call and Webcast on August 14, 2025
July 24, 2025
DRI Healthcare Comments on FDA Approval and our Increased Investment in KalVista Pharmaceuticals' Ekterly® (sebetralstat)
July 8, 2025
DRI Healthcare Announces Closing of Internalization Transaction
July 1, 2025
DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints
June 13, 2025
DRI Healthcare Trust Announces Appointment of Annalisa King to Board of Trustees and as Chair of the Audit Committee
June 9, 2025
DRI Healthcare Trust Announces Voting Results of AGM
May 13, 2025
DRI Healthcare Trust Reports First Quarter 2025 Results and Announces Internalization of Manager
May 12, 2025
DRI Healthcare Trust to Host First Quarter 2025 Earnings Call and Webcast on May 13, 2025
April 22, 2025
Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday
March 5, 2025
DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results
March 3, 2025
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2024 Earnings Call and Webcast on March 4, 2025
January 29, 2025
DRI Healthcare Trust Declares Special Unit Distribution
December 20, 2024
DRI Healthcare Trust Reports Third Quarter 2024 Results
November 6, 2024
DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of He...
November 4, 2024
DRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities
November 1, 2024
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 7, 2024
October 11, 2024
DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene ...
October 3, 2024
DRI Healthcare Trust Reports Second Quarter 2024 Results
August 6, 2024
DRI Healthcare Trust and DRI Capital Inc. Announce Executive Changes
July 8, 2024
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024
July 3, 2024
DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) f...
July 2, 2024
DRI Healthcare Trust Reports First Quarter 2024 Results
May 6, 2024
DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities
April 23, 2024
DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 7, 2024
April 16, 2024
DRI Healthcare Trust Announces Refinancing of Preferred Securities
April 15, 2024
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
March 26, 2024
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2023 Results
February 28, 2024
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2023 Earnings Call and Webcast on February 29, 2024
February 8, 2024
DRI Healthcare Trust Announces the Expansion of its Royalty Entitlement on the US Net Sales of Omidria®, Updates Deployment and CAGR...
February 1, 2024